SSRI CHINA news

Previously (in July 2018), we shared the top 15 pharmaceutical companies with the highest sales rep visitation rates in China according to the PatientsMap 2018 CN data (table 2).

This time, we are sharing the top 5 pharmaceutical companies with the highest sales rep visitation rates in specific clinical departments, in particular, clinical departments with relatively strong domestic company presence.

Table 1 shows the top 5 companies with highest sales rep visitation rates in 10 clinical departments (e.g. 48.7% of 476 gastroenterologists met a sales rep from AstraZeneca in the past month). While major global companies generally occupy the top 3 spots, there are also some domestic companies such as Chia-Tai Tianqing (CTTQ) Pharmaceutical and Jiangsu Hengrui Medicine that rank highly in some clinical departments. In particular, domestic companies occupy the top 3 stops in the anesthesiology department.

In terms of domestic companies, Hengrui ranks second in radiology and anesthesiology departments and third in RA/immunology and oncology departments; and CTTQ ranks second in gastroenterology and infectious diseases departments and third in hematology department.

The rankings for all 32 clinical departments are available in the PatientsMap 2018 CN database.

Table 1. Top 5 sales rep visits (10 departments)

Table 2. PatientsMap 2018 CN – top 15 sales rep visits (n=10,285) from July 2018 news release